068270 logo

Celltrion Inc (068270)

Celltrion, Inc., a biopharmaceutical company, engages in the development, production, and sale of development, production, and sale of medicinal products. It offers biosimilars, including Remsima for rheumatoid arthritis and inflammatory bowel disease; Truxima for non-hodgkin's lymphoma and chronic lymphocytic leukemia; Herzuma for metastatic breast and gast...

KOHealthcareBiotechnologyKorea

Company Profile

Stock Code
068270
ISIN Code
KR7068270008
Currency
Korean Won (KRW)
IPO Date
2005-07-19

Contact Information

Company Address
23, Academy-ro, Incheon, South Korea
Contact Phone
82 3 2850 5000
Company Website
https://www.celltrion.com
Fiscal Year End
December

Financial Highlights

Market Capitalization
$999,999.99
Gross Profit (TTM)
$999,999.99
Dividend Yield
0.37%
Return on Assets (TTM)
4.37%
EBITDA
$999,999.99
Revenue (TTM)
$999,999.99